Literature DB >> 32469227

Contribution of selected vasoactive systems to blood pressure regulation in two models of chronic kidney disease.

N Drábková1, S Hojná, J Zicha, I Vaněčková.   

Abstract

It is generally accepted that angiotensin II plays an important role in high blood pressure (BP) development in both 2-kidney-1-clip (2K1C) Goldblatt hypertension and in partial nephrectomy (NX) model of chronic kidney disease (CKD). The contribution of sympathetic nervous system and nitric oxide to BP control in these models is less clear. Partial nephrectomy or stenosis of the renal artery was performed in adult (10-week-old) male hypertensive heterozygous Ren-2 transgenic rats (TGR) and normotensive control Hannover Sprague Dawley (HanSD) rats and in Wistar rats. One and four weeks after the surgery, basal blood pressure (BP) and acute BP responses to the consecutive blockade of renin-angiotensin (RAS), sympathetic nervous (SNS), and nitric oxide (NO) systems were determined in conscious rats. Both surgical procedures increased plasma urea, a marker of renal damage; the effect being more pronounced following partial nephrectomy in hypertensive TGR than in normotensive HanSD rats with a substantially smaller effect in Wistar rats after renal artery stenosis. We demonstrated that the renin-angiotensin system does not play so fundamental role in blood pressure maintenance during hypertension development in either CKD model. By contrast, a more important role is exerted by the sympathetic nervous system, the activity of which is increased in hypertensive TGR-NX in the developmental phase of hypertension, while in HanSD-NX or Wistar-2K1C it is postponed to the established phase. The contribution of the vasoconstrictor systems (RAS and SNS) was increased following hypertension induction. The role of NO-dependent vasodilation was unchanged in 5/6 NX HanSD and in 2K1C Wistar rats, while it gradually decreased in 5/6 NX TGR rats.

Entities:  

Mesh:

Year:  2020        PMID: 32469227      PMCID: PMC8648315          DOI: 10.33549/physiolres.934392

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  27 in total

1.  Partial nephrectomy and chronic renal failure: the 'mature' rat model.

Authors:  N Gretz; E Meisinger; M Strauch
Journal:  Contrib Nephrol       Date:  1988       Impact factor: 1.580

2.  Unraveling the Mystery of Goldblatt Hypertension.

Authors:  L. Gabriel Navar; Lixian Zou; Annette Von Thun; Chi Tarng Wang; John D. Imig; Kenneth D. Mitchell
Journal:  News Physiol Sci       Date:  1998-08

3.  Effects of combined endothelin A receptor and renin-angiotensin system blockade on the course of end-organ damage in 5/6 nephrectomized Ren-2 hypertensive rats.

Authors:  Ivana Vaněčková; Petr Kujal; Zuzana Husková; Zdeňka Vaňourková; Zdenka Vernerová; Věra Certíková Chábová; Petra Skaroupková; Herbert J Kramer; Vladimír Tesař; Luděk Červenka
Journal:  Kidney Blood Press Res       Date:  2012-04-04       Impact factor: 2.687

Review 4.  Pathophysiology of resistant hypertension in chronic kidney disease.

Authors:  Vito M Campese
Journal:  Semin Nephrol       Date:  2014       Impact factor: 5.299

5.  Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure.

Authors:  D P Brooks; B G Short; M J Cyronak; L C Contino; M DiCristo; Y X Wang; R R Ruffolo
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

6.  Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats.

Authors:  Agnieszka Walkowska; Petra Skaroupková; Zuzana Husková; Zdenka Vanourková; Vera Certíková Chábová; Vladimír Tesar; Herbert J Kramer; John R Falck; John D Imig; Elzbieta Kompanowska-Jezierska; Janusz Sadowski; Ludek Cervenka
Journal:  J Hypertens       Date:  2010-03       Impact factor: 4.844

7.  Angiotensin and angiotensin converting enzyme tissue levels in two-kidney, one clip hypertensive rats.

Authors:  S Guan; J Fox; K D Mitchell; L G Navar
Journal:  Hypertension       Date:  1992-12       Impact factor: 10.190

8.  Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats.

Authors:  Marcin Adamczak; Marie-Luise Gross; Jan Krtil; Andreas Koch; Karin Tyralla; Kerstin Amann; Eberhard Ritz
Journal:  J Am Soc Nephrol       Date:  2003-11       Impact factor: 10.121

9.  Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat.

Authors:  V M Campese; E Kogosov; M Koss
Journal:  Am J Kidney Dis       Date:  1995-11       Impact factor: 8.860

10.  Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats.

Authors:  Petr Kujal; Vera Čertíková Chábová; Petra Škaroupková; Zuzana Husková; Zdena Vernerová; Herbert J Kramer; Agnieszka Walkowska; Elzbieta Kompanowska-Jezierska; Janusz Sadowski; Kento Kitada; Akira Nishiyama; Sung H Hwang; Bruce D Hammock; John D Imig; Ludek Červenka
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-03       Impact factor: 2.557

View more
  3 in total

Review 1.  The organ-specific nitric oxide synthase activity in the interaction with sympathetic nerve activity: a hypothesis.

Authors:  S Liskova
Journal:  Physiol Res       Date:  2021-04-30       Impact factor: 1.881

2.  Effect of iron oxide nanoparticles on vascular function and nitric oxide production in acute stress-exposed rats.

Authors:  S Líšková; P Bališ; A Mičurová; M Kluknavský; M Okuliarová; A Puzserová; M Škrátek; I Sekaj; J Maňka; P Valovič; I Bernátová
Journal:  Physiol Res       Date:  2020-11-02       Impact factor: 1.881

Review 3.  Mechanisms Modified by (-)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies.

Authors:  Iveta Bernatova; Silvia Liskova
Journal:  Antioxidants (Basel)       Date:  2021-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.